Abstract:Rationale: The resolution of inflammation is an active process coordinated by mediators and immune cells to restore tissue homeostasis. However, the mechanisms for resolving eosinophilic allergic lung inflammation triggered by inhaled allergens have not been fully elucidated. Objectives: Our objectives were to investigate the cellular mechanism of tissue-resident macrophages involved in the resolution process of eosinophilic lung inflammation. Methods: For the study, we used the institutional review board-approved protocol for human subsegmental bronchoprovocation with allergen, mouse models for allergic lung inflammation, and novel transgenic mice, including a conditional CCL26 knockout. The samples were analyzed using mass cytometry, single-cell RNA sequencing, and biophysical and immunological analyses. Measurements and Main Results: We compared alveolar macrophage (AM) subsets in the BAL before and after allergen provocation. In response to provocation with inhaled allergens, the subsets of AMs are dynamically changed in humans and mice. In the steady state, the AM subset expressing CX3CR1 is a relatively small fraction in bronchoalveolar space and lung tissue but drastically increases after allergen challenges. This subset presents unique patterns of gene expression compared with classical AMs, expressing high C1q family genes. CX3CR1+ macrophages are activated by airway epithelial cell-derived CCL26 via a receptor-ligand interaction. The binding of CCL26 to the CX3CR1+ receptor induces CX3CR1+ macrophages to secrete C1q, subsequently facilitating the clearance of eosinophils. Furthermore, the depletion of CX3CR1 macrophages or CCL26 in airway epithelial cells delays the resolution of allergic lung inflammation displaying prolonged tissue eosinophilia. Conclusions: These findings indicate that the CCL26-CX3CR1 pathway is pivotal in resolving eosinophilic allergic lung inflammation.

Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

Eosinophils Promote Pulmonary Matrix Destruction and Emphysema Via Cathepsin L

Eosinophils Protect Against Pulmonary Hypertension Through 14-HDHA and 17-HDHA

15-epi-lipoxin A5 promotes neutrophil exit from exudates for clearance by splenic macrophages

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Cys-leukotrienes mediate lung dysfunction but not histopathologies in an IL-5/Eotaxin-2 double transgenic mouse model of severe asthma

12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation

Emerging Role of Eosinophils in Resolution of Arthritis

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

CX 3 CR 1 + Macrophage Facilitates the Resolution of Allergic Lung Inflammation via Interacting CCL26

15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling Treg cell function through IFN-β

Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

TGF-β signaling promotes eosinophil activation in inflammatory responses

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

Frontline Science: Eosinophil-Deficient Mbp-1 and Epx Double-Knockout Mice Link Pulmonary Remodeling and Airway Dysfunction with Type 2 Inflammation

Characterization of the immune suppressive functions of eosinophils

Cys-Leukotrienes Promote Fibrosis in a Mouse Model of Eosinophil-Mediated Respiratory Inflammation

Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation

Eosinophils prevent diet-induced airway hyperresponsiveness in mice on a high-fat diet